Tag: Evotec

Evotec Announced Acquisition of Just Biotherapeutics

Evotec SE announced the signing of a definitive agreement under which Evotec will acquire Just Biotherapeutics, Inc., for up to $ 90 m including potential performance-based earn-out components expecte...

Evotec and Indivumed GmbH Will Work Together to Discover the Treatment of Colorectal Cancer

Evotec and Indivumed GmbH have entered into a research collaboration to discover and develop first-in-class therapeutics for the treatment of colorectal cancer ("CRC"). The collaboration, which run...

Evotec and Galapagos to Focus on Fibrosis

Evotec AG and Galapagos NV announced a global collaboration focused on a novel target for fibrosis and other indications. The collaboration concerns a small molecule programme, currently in pre-cli...

Evotec sets up a drug discovery alliance with LEO Pharma

pharma
Evotec AG (Germany) announced a new integrated drug discovery alliance with LEO Pharma (Denmark), a global leader in medical dermatology.

Evotec starts AI-driven drug discovery collaboration with Immuneering

lab plates
Evotec AG (Germany), a drug discovery alliance and development partnership company, announced that it has entered into a research collaboration with Immuneering Corporation (USA).

Ferring and Evotec to create a research alliance in reproductive medicine

lab plates
Ferring Pharmaceuticals and Evotec AG announced a strategic research alliance to discover and develop new small molecule therapies to treat patients with fertility and gynaecological conditions.

Evotec launches a new drug discovery initiative with Sanofi

drug discovery
Evotec AG announced that it has established an initiative with Sanofi through the launch of a BRIDGE, called LAB031, designed to accelerate drug discovery across multiple therapeutic areas.

Evotec and Almirall started a drug discovery collaboration

drug development
Evotec AG (Germany) and Almirall S.A. (Spain), a leading skin-health focused global pharmaceutical company, announced that they have entered into a research collaboration.

Evotec and Celgene to collaborate on targeted protein degradation

evotec
Evotec AG announced that Evotec and Celgene Corporation have entered into a third long-term strategic drug discovery and development partnership in the field of targeted protein degradation.

Evotec enters a drug discovery partnership with Centogene

lab-tubes
Evotec AG announced that CENTOGENE and Evotec entered into a global strategic collaboration agreement for joint drug discovery projects, developing compounds to treat rare genetic diseases.

Evotec sets up alliance with Novo Nordisk to develop novel diabetes therapies

diabetes
Evotec AG announced a strategic alliance with Novo Nordisk to discover and develop novel small molecule therapies to treat patients suffering from diabetes and obesity.

Stealth BioTherapeutics develops new drug in collaboration with Evotec

clinical-trials
Stealth BioTherapeutics announced that it is advancing a new pipeline candidate into investigational new drug (IND) enabling studies in collaboration with long-term partner Evotec AG.

Evotec partner Haplogen starts drug discovery collaboration with Bayer

drug-development
Haplogen, a biotechnology company, has entered into a multi-year drug discovery and development collaboration with Bayer AG to identify new therapeutics with applications in pulmonary diseases.

Evotec receives €3 million payment from Sanofi

stem cells
Evotec AG announced that its strategic alliance (TargetBCD) with Sanofi in the field of diabetes has reached its second beta cell therapy milestone, resulting in a payment of €3 million to Evotec.

Evotec and Sanofi join forces to fight infectious diseases

microbiology plates
Evotec signed a transaction agreement with Sanofi to integrate Sanofi’s infectious disease unit into its organisation. Evotec will also licence-in the majority of Sanofi’s infectious disease research portfolio and initiatives.

Evotec and Celgene started oncology partnership

laboratory
Evotec AG announced that Evotec and Celgene Corporation have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology.